US Product Launches To Plan For In 2020

 
• By John Davis

A sizeable group of key late-stage products have the potential to reach the US market in 2020, according to a recent report from Informa’s Biomedtracker. Pharmaceutical and biotech executives will have to be on their A-game to integrate the new wave of products into patient-centric and market access-friendly commercial strategies.  

Rocket
Launches need to be planned well in advance. • Source: Shutterstock

More from New Products

More from Scrip